Financials Tempus AI, Inc

Equities

TEM

US88023B1035

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:03 2024-07-12 pm EDT 5-day change 1st Jan Change
39.75 USD +6.00% Intraday chart for Tempus AI, Inc +28.72% 0.00%

Valuation

Fiscal Period: December 2024 2025 2026
Capitalization 1 6,554 - -
Enterprise Value (EV) 1 6,457 6,477 6,568
P/E ratio -8.63 x -28.8 x -52.7 x
Yield - - -
Capitalization / Revenue 9.49 x 7.11 x 5.33 x
EV / Revenue 9.35 x 7.02 x 5.34 x
EV / EBITDA -55.7 x -196 x 65.9 x
EV / FCF -35.2 x -161 x 140 x
FCF Yield -2.84% -0.62% 0.71%
Price to Book 91.5 x 1,048 x 105 x
Nbr of stocks (in thousands) 164,833 - -
Reference price 2 39.76 39.76 39.76
Announcement Date - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 531.8 690.5 922.1 1,230
EBITDA 1 - -116 -33.01 99.72
EBIT 1 - -294.3 -104.3 20.9
Operating Margin - -42.63% -11.31% 1.7%
Earnings before Tax (EBT) 1 - -560.3 -163.9 -73.8
Net income 1 -214.1 -746.8 -231.4 -134.4
Net margin -40.26% -108.16% -25.1% -10.92%
EPS 2 - -4.606 -1.378 -0.7548
Free Cash Flow 1 - -183.6 -40.27 46.93
FCF margin - -26.59% -4.37% 3.82%
FCF Conversion (EBITDA) - - - 47.07%
FCF Conversion (Net income) - - - -
Dividend per Share 2 - - - -
Announcement Date 5/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 160.3 179.2 206.3 199.3 223.9
EBITDA 1 -37.69 -25.69 -8.815 -6.55 -4.15
EBIT 1 -119.6 -40.41 -23.16 -23.99 -18.11
Operating Margin -74.62% -22.55% -11.23% -12.03% -8.09%
Earnings before Tax (EBT) 1 -389.9 -60.93 -44.63 -54.75 -53.55
Net income 1 -557.2 -72.19 -55.06 -57.17 -54.73
Net margin -347.61% -40.29% -26.69% -28.68% -24.45%
EPS 2 -3.380 -0.4323 -0.3336 -0.3250 -0.3200
Dividend per Share - - - - -
Announcement Date - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt 1 - - - 14.1
Net Cash position 1 - 96.8 77.2 -
Leverage (Debt/EBITDA) - - - 0.1413 x
Free Cash Flow 1 - -184 -40.3 46.9
ROE (net income / shareholders' equity) - - -118% 14.1%
ROA (Net income/ Total Assets) - -26.3% -9.72% 1.83%
Assets 1 - 2,837 2,382 -7,358
Book Value Per Share 2 - 0.4300 0.0400 0.3800
Cash Flow per Share 2 - -1.670 -1.140 -
Capex 1 - 12.8 9.75 9.73
Capex / Sales - 1.86% 1.06% 0.79%
Announcement Date 5/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
39.76 USD
Average target price
45.29 USD
Spread / Average Target
+13.90%
Consensus
  1. Stock Market
  2. Equities
  3. TEM Stock
  4. Financials Tempus AI, Inc